E99
Pill imprint E99 has been identified as Cefdinir 300 mg.
Cefdinir is used in the treatment of bronchitis; sinusitis; pneumonia; otitis media; strep throat (and more), and belongs to the drug class third generation cephalosporins. There is no proven risk in humans during pregnancy.
Cefdinir 300 mg is not subject to the Controlled Substances Act.
See also related documents.
Cefdinir Images
- Imprint:
-
E99
- Strength:
- 300 mg
- Color:
- Purple / Blue
- Size:
- 21.00 mm
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Inactive Ingredients:
- carboxymethylcellulose calcium
silicon dioxide
magnesium stearate
FD&C Blue No. 1
D&C Red No. 28
titanium dioxide
gelatin
sodium lauryl sulfate
ferrosoferric oxide
shellac
- Drug Class:
- Third generation cephalosporins
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Aurobindo Pharma
- National Drug Code (NDC):
- 65862-0177
| NDC Code | Manufacturer / Repackager |
|---|---|
| 59762-2180 | Greenstone LLC |
Note: Inactive ingredients may vary.
More Cefdinir resources
- Cefdinir (Wolters Kluwer)
- Cefdinir Suspension (Wolters Kluwer)
- cefdinir (Cerner Multum)
- cefdinir (Micromedex) - Includes Dosage Information
- Cefdinir (AHFS DI)
- Cefdinir (FDA)
- Cefdinir Capsules (FDA)
- Cefdinir (Wolters Kluwer)


